Welcome to our dedicated page for Carecloud news (Ticker: CCLDP), a resource for investors and traders seeking the latest updates and insights on Carecloud stock.
News and press releases related to CareCloud, Inc. and the preferred stock context of CCLDP focus on the company’s role as a healthcare technology and AI-driven solutions provider for medical practices, hospitals, integrated health systems, and other healthcare organizations. These updates highlight how CareCloud applies AI and technology-enabled tools to revenue cycle management, electronic health records, practice management, analytics, and patient experience management.
Investors following CareCloud-related news can review announcements about new AI products, strategic acquisitions, capital structure decisions, and financial performance. Examples include the launch of stratusAI Desk Agent, an AI phone receptionist designed to automate patient phone interactions and manage high-volume calls, and the introduction of stratusAI Voice Audit, a conversational intelligence platform that provides insights into call quality, volumes, and patient sentiment. Together, these products illustrate how the company is integrating generative AI into real-world healthcare workflows.
News items also cover CareCloud’s expansion in the inpatient and hospital software markets, such as the acquisition of Medsphere Systems Corporation assets and the agreement to acquire HFMA’s MAP App, a hospital benchmarking tool for revenue cycle performance. These stories describe how CareCloud is broadening its SaaS-based ecosystem with tools that complement its AI-powered revenue cycle platform and extend its reach across the full care continuum.
In addition, CareCloud’s press releases provide regular updates on quarterly results, revenue guidance, profitability trends, and preferred stock dividend policies. Communications about its 8.75% Series A and Series B Cumulative Redeemable Perpetual Preferred Stock, including dividend declarations, arrears catch-up plans, and the mandatory conversion and delisting of Series A Preferred Stock, give context for investors tracking securities associated with tickers like CCLDP and CCLDO. For ongoing insight into CareCloud’s strategy, AI roadmap, acquisitions, and capital decisions, readers can monitor this news feed as new filings and announcements are released.
CareCloud (Nasdaq: CCLD, CCLDO) declared monthly cash dividends for its 8.75% Series A and Series B perpetual preferred shares for January, February and March 2026, and an additional Series B dividend to cover an arrearage.
The declared monthly dividend per share is $0.18229 for Series A, Series B and the Series B additional payment. Ex-dividend/record dates are the last day of each month (Jan 31, Feb 28, Mar 31, 2026) and payment dates are Feb 17, Mar 16 and Apr 15, 2026. The annual preference equals 8.75% of $25.00 (or $2.1875 per share).
Series A was mandatorily converted and delisted after March 6, 2025. Series B continues to trade under CCLDO and carries scheduled redemption prices that decline over time, with special redemption terms on a Change of Control.
CareCloud (Nasdaq: CCLD) announced on Jan 8, 2026 that Affinity Urgent Care (Houston–Galveston) selected Wellsoft, the emergency department information system CareCloud acquired when it bought Medsphere in August 2025. The move brings an emergency-grade documentation platform into the urgent care channel, addressing an estimated 11,000 U.S. urgent care facilities and targeting higher-acuity, high-throughput outpatient workflows.
CareCloud positions Wellsoft alongside its AI-driven ambulatory, RCM, practice management, analytics, and patient engagement tools to support faster triage, integrated diagnostics, and staffing efficiency. Wellsoft has prior KLAS recognition as a category leader in emergency medicine through 2020.
CareCloud (NASDAQ: CCLD) announced leadership changes effective January 1, 2026 to accelerate its enterprise AI strategy and scale execution. A. Hadi Chaudhry will serve as Chief Strategy Officer to lead the company-wide AI platform and innovation; Stephen Snyder will serve as Chief Executive Officer to focus on disciplined execution, margin expansion, and scaling AI solutions across ambulatory and hospital markets.
The company highlighted recent margin expansion, improved cash flow consistency, and that it remains on track for its first year of positive EPS since going public. CareCloud also expanded into the inpatient software market via acquisitions of Medsphere Systems and the HFMA MAP App.
CareCloud (Nasdaq: CCLD) on Dec 15, 2025 launched stratusAI Desk Agent, an AI phone receptionist designed to automate patient phone access with 24/7, no-wait voice conversations and deep EHR/PM integration. The company says the solution handles front-desk workflows end-to-end, including appointment scheduling, triage, prescription refills, referrals, lab questions, and reminders. A customer quote reports the agent is managing nearly 80% of inbound calls at one practice. CareCloud positions stratusAI Desk Agent alongside stratusAI Voice Audit to deliver call monitoring, quality scoring, trending insights, and sentiment visibility. The product is available now to CareCloud customers and a live demo webinar is scheduled for Dec 17, 2025.
CareCloud (Nasdaq: CCLD / CCLDO) announced a formal plan to satisfy 14 months of unpaid dividends on its 8.75% Series B cumulative preferred stock by issuing double monthly payments starting with the January 2026 dividend (record date Jan 31, 2026; payment expected mid‑February 2026).
The arrears total approximately $3.9 million or $2.55 per share. Regular monthly dividends were fully reinstated in January 2025. The company says it will use internally generated cash flow (no common dilution) and expects arrears to be fully paid by the end of Q1 2027, while reserving the right to adjust timings for unforeseen circumstances.
CareCloud (Nasdaq: CCLD) reported third quarter 2025 results and raised full-year revenue guidance to $117–$119 million (previously $111–$114M). Q3 revenue was $31.1 million, up 9% year-over-year, marking six consecutive quarters of positive GAAP net income. Q3 GAAP net income was $3.1 million and adjusted EBITDA was $7.7 million (up 13% YoY). Nine-month revenue was $86.1 million (+4% YoY) and YTD adjusted EBITDA was $19.9 million. The company completed the Medsphere acquisition for a total purchase price of $16.5 million, reduced line-of-credit borrowings to $4.9 million, and launched an AI Center of Excellence to scale generative AI initiatives.
CareCloud (Nasdaq: CCLD) will present at the ThinkEquity Conference on October 30, 2025 at the Mandarin Oriental, New York City. The company's presentation is scheduled for 4:00 p.m. ET in the Lotus Suite East and will focus on AI innovation and its overall growth strategy.
CareCloud will also highlight four year-to-date transactions, including the Medsphere acquisition and the addition of HFMA’s MAP App, which the company says expanded its capabilities and client reach.
CareCloud (Nasdaq: CCLD) will present at the 2025 Maxim Growth Summit on October 22–23, 2025 at the Hard Rock Hotel New York City.
Presentation will highlight recent M&A activity (four transactions year‑to‑date, including the Medsphere acquisition in late August and the HFMA MAP App acquisition earlier this month), the Company’s AI roadmap and AI Center of Excellence scaling toward ~500 AI professionals, raised 2025 revenue guidance to $116–$118 million, positive free cash flow, resumption of preferred dividends, and inclusion in the Russell Microcap Index.
CareCloud (Nasdaq: CCLD) will release third quarter 2025 financial results for the period ended September 30, 2025 before the market opens on Thursday, November 6, 2025. A conference call for investors is scheduled for 8:30 a.m. Eastern Time the same day. A live webcast and presentation slides will be available at ir.carecloud.com/events; an audio-only option is available via dial-in numbers. A replay and slides will be posted roughly three hours after the call at the same link.
CareCloud (Nasdaq: CCLD, CCLDO) announced monthly cash dividends for its 8.75% Series A and Series B cumulative perpetual preferred shares for October, November and December 2025.
Key facts: monthly dividend per share $0.18229 for each series; Series A holders receive an additional payment tied to a prior 11% rate that equals $0.04688 (Oct), $0.01719 (Nov) and $0.00 (Dec); ex-dividend and record dates are the last day of each month (Oct 31, Nov 30, Dec 31, 2025); payment dates are Nov 17, 2025, Dec 15, 2025 and Jan 15, 2026.
Dividends are cumulative, calculated at 8.75% per annum on the $25 liquidation preference (equivalent to $2.1875 per annum per share). Previously converted Series A holders who converted on March 6, 2025 are not eligible for these payments.